Valuation check: VERO's profit margin is -173.57%, below the Healthcare sector average of 9.48%.
Get informed when a big investor buys or sells
+ FollowAs of Sep 2025
Trailing 12 months ending Sep 2025
The latest profit margin for VERO is -173.57% as of September 2025. That compares with -80.76% in the prior-year period — down 114.9% year over year. That is below the Healthcare sector average of 9.48%. Investors often review this figure alongside Venus Concept's historical trend and sector peers before judging valuation or financial health.
Over the past year, VERO's profit margin moved from -80.76% to -173.57% — a 114.9% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Venus Concept's valuation or profitability profile.
Against Healthcare companies, VERO currently prints -173.57% for profit margin, while the sector average sits near 9.48%. That is roughly 1930.8% below the sector mean. Large gaps often invite a closer look at Venus Concept's growth, margins, and balance sheet.
Profit Margin shows how effectively Venus Concept converts resources into returns. At -173.57%, VERO may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -80.76% in the prior-year period — down 114.9% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting VERO's profit margin (-173.57%), review year-over-year change from -80.76%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.